Developing tools to boost the efficiency of toxicological assessments and to enable technical and non-technical users to make clear decisions about the safe use of materials.
Providing toxicology and management consulting services supporting clients including the U.S. Food and Drug Administration in the development of Janus Nonclinical, a tool designed to allow toxicological reviewers of new drug submissions the ability to analyze study data and create summary tables more efficiently using electronic submission via the Standard for Exchange of Nonclinical Data. Continuing support for training of reviewers as the FDA goes through this monumental shift in the review process.